Background illustration for clinical trials search

Paid Clinical Trials Denton

Discover 1,918 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,918

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for

Non-small Cell Lung Cancer

Location: Fort Worth TX, Round Rock TX, Shreveport LA,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06692738

Phase3, Recruiting

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

for

Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis,

Location: Fort Worth TX, Dallas TX, San Antonio TX,

Sponsor: Alebund Pharmaceuticals

Sex: All

Age: 12+

Code: NCT06933472

Phase3, Recruiting

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

for

Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis,

Location: Southlake TX, Garland TX, Cedar Park TX, San Antonio TX,

Sponsor: Spyre Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07012395

Phase2, Recruiting

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

for

Systemic Sclerosis, Idiopathic Inflammatory Myopathies,

Location: Dallas TX, Houston TX, Fairway KS, Chicago IL,

Sponsor: Nkarta, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06733935

Phase1, Phase2, Recruiting

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

for

Lupus Nephritis, Primary Membranous Nephropathy

Location: Dallas TX, Houston TX, Little Rock AR, New Orleans LA,

Sponsor: Nkarta, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06557265

Phase1, Phase2, Recruiting

A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

for

Dravet Syndrome

Location: Fort Worth TX, Austin TX, Houston TX, Little Rock AR,

Sponsor: Longboard Pharmaceuticals

Sex: All

Age: 2 - 65

Code: NCT06660394

Phase3, Recruiting

WRAP North America

for

Venous Stenosis, Venous Occlusion

Location: Fort Worth TX, Humble TX, Dothan AL, Lexington KY,

Sponsor: Merit Medical Systems, Inc.

Sex: All

Age: 18+

Code: NCT06807099

Recruiting

Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age

for

Catheter-Related Infections

Location: Fort Worth TX, Birmingham AL, Phoenix AZ, Wilmington DE,

Sponsor: CorMedix Therapeutics

Sex: All

Age: 0 - 17

Code: NCT06714864

Recruiting

A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis

for

Eosinophilic Esophagitis (EoE)

Location: Fort Worth TX, Aurora CO, Atlanta GA, Milwaukee WI,

Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 0 - 6

Code: NCT07112378

Phase3, Recruiting

Childhood Cancer Survivor Study

for

Cancer

Location: Fort Worth TX, Houston TX, Memphis TN, St Louis MO,

Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0+

Code: NCT01120353

Recruiting

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

for

Staphylococcus Aureus

Location: Dallas TX, Houston TX, Beaumont TX, Kansas City MO,

Sponsor: AstraZeneca

Sex: All

Age: 18 - 55

Code: NCT06749457

Phase1, Phase2, Recruiting

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

for

Multiple Myeloma

Location: Fort Worth TX, Nashville TN, Chattanooga TN,

Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT05714839

Phase1, Phase2, Recruiting

Featured

A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)

for

Hepatocellular Carcinoma

Location: Dallas TX, Abilene TX, St Louis MO, Louisville KY,

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06109272

Phase2, Phase3, Recruiting

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

for

Lymphoblastic Lymphoma, Acute Lymphoblastic Leukemia ALL

Location: Fort Worth TX, Houston TX, Aurora CO, Indianapolis IN,

Sponsor: Allterum Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT07586618

Phase1, Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for

Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,

Location: Fort Worth TX, Dallas TX, Oklahoma City OK, Austin TX,

Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase3, Recruiting

Sickle Cell Kidney Biorepository

for

Sickle Cell Trait, Sickle Cell Disease (SCD),

Location: Dallas TX

Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 65

Code: NCT07064174

Recruiting

A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

for

Dravet Syndrome

Location: Fort Worth TX, Aurora CO, Rochester MN, Chicago IL,

Sponsor: Encoded Therapeutics

Sex: All

Age: 0 - 17

Code: NCT05419492

Phase1, Phase2, Recruiting

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

for

Crohn's Disease

Location: Fort Worth TX, Atlanta GA, Indianapolis IN, London,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 2 - 17

Code: NCT05923073

Phase3, Recruiting

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

for

Refractory Acute Myeloid Leukemia,

Location: Fort Worth TX, Dallas TX, Memphis TN, Kansas City MO,

Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 1 - 30

Code: NCT06177067

Phase1, Recruiting

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

for

Spinal Muscular Atrophy (SMA)

Location: Fort Worth TX, Houston TX, San Antonio TX,

Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 0+

Code: NCT04174157

Recruiting

Paid Clinical Trials Denton

Filter results

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

Interested in new trials?

A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

WRAP North America

Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age

A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis

Childhood Cancer Survivor Study

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Sickle Cell Kidney Biorepository

A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)